AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15069129 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injection
Number of subjects: 100
Study 15069129 — intervention group
Group type: COMPARATOR
Intervention: Discectomy
Number of subjects: 100
Study 11315891 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0 mm endoscope
Number of subjects: 322
Study 11315891 — intervention group
Group type: COMPARATOR
Intervention: 9.8 mm endoscope
Number of subjects: 322
Study 9398103 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitalis (deslanoside 0.01 mg/kg)
Number of subjects: 13
Study 9398103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 7514506 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone PCA (0.1 mg/hr basal infusion, 0.2 mg Q 5 min bolus, max 1.2 mg/hr)
Number of subjects: 0
Study 7514506 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesic therapy (CAT) with morphine 2.5 mg iv Q 30 min prn until extubation, followed by meperidine 1 mg/kg im Q 4 hr or acetaminophen 325 mg with codeine 30 mg po (1 or 2 tablets) when oral intake possible
Number of subjects: 0
Study 2892256 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg
Number of subjects: 10
Study 2892256 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 10
Study 2892256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 10
Study 2892256 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg
Number of subjects: 10
Study 2892256 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg
Number of subjects: 10
Study 2892256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31949115 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefapixant (doses ≥30 mg)
Number of subjects: 0
Study 31949115 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefapixant (doses ≥150 mg)
Number of subjects: 0
Study 31949115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30538021 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia RElAted Manual for Sleep; STrAtegies for RelaTives (DREAMS START) - a six-session manual-based intervention for carers, delivered by trained psychology graduates.
Number of subjects: 62
Study 30538021 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 62
Study 28379925 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically graded bee honey at 5 g/day
Number of subjects: 40
Study 28379925 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically graded bee honey at 10 g/day
Number of subjects: 40
Study 28379925 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically graded bee honey at 15 g/day
Number of subjects: 40
Study 28379925 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 g/day honey)
Number of subjects: 40
Study 25741642 — intervention group
Group type: EXPERIMENTAL
Intervention: NIH ARDS Network PBW equation
Number of subjects: 0
Study 25741642 — intervention group
Group type: COMPARATOR
Intervention: Actuarial table PBW equation
Number of subjects: 0
Study 25741642 — intervention group
Group type: COMPARATOR
Intervention: Stewart PBW equation
Number of subjects: 0
Study 25741642 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 0
Study 23076993 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular-specific neuromuscular training for six weeks
Number of subjects: 23
Study 23076993 — intervention group
Group type: COMPARATOR
Intervention: Regular activities at school
Number of subjects: 23
Study 22229233 — intervention group
Group type: EXPERIMENTAL
Intervention: intradermal non-absorbable suture
Number of subjects: 140
Study 22229233 — intervention group
Group type: EXPERIMENTAL
Intervention: intradermal non-absorbable double layer suture
Number of subjects: 140
Study 22229233 — intervention group
Group type: EXPERIMENTAL
Intervention: staples
Number of subjects: 140
Study 22229233 — intervention group
Group type: COMPARATOR
Intervention: tissue adhesive
Number of subjects: 140
Study 19178577 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BT‐A)
Number of subjects: 23
Study 19178577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 23
Study 16846450 — intervention group
Group type: EXPERIMENTAL
Intervention: Mite allergen impermeable mattress covers
Number of subjects: 1282
Study 16846450 — intervention group
Group type: COMPARATOR
Intervention: Placebo covers
Number of subjects: 1282
Study 16846450 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1282
Study 12970916 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN) and enteral nutrition (EN) therapies
Number of subjects: 96
Study 12970916 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) via central venous infusion
Number of subjects: 96
Study 11169275 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 109
Study 8599322 — intervention group
Group type: EXPERIMENTAL
Intervention: 56.3 mmol acetate/L
Number of subjects: 6
Study 8599322 — intervention group
Group type: EXPERIMENTAL
Intervention: 18.7 mmol propionate/L
Number of subjects: 6
Study 8599322 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate and propionate together
Number of subjects: 6
Study 8599322 — intervention group
Group type: EXPERIMENTAL
Intervention: 18.7 mmol acetate/L
Number of subjects: 6
Study 8599322 — intervention group
Group type: EXPERIMENTAL
Intervention: 56.3 mmol propionate/L
Number of subjects: 6
Study 1457388 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/ml fluphenazine decanoate formulation
Number of subjects: 16
Study 1457388 — intervention group
Group type: COMPARATOR
Intervention: 25 mg/ml standard fluphenazine decanoate formulation
Number of subjects: 16
Study 1457388 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-injection serum fluphenazine levels in a subgroup of 10 patients
Number of subjects: 16
Study 6374050 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-based chemotherapy regimens (cyclophosphamide and doxorubicin alone or in combination with methotrexate or cisplatin)
Number of subjects: 537
Study 6374050 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-based chemotherapy regimens
Number of subjects: 537
Study 6374050 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 537
Study 31192908 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release oxycodone (tablets, 12 hourly)
Number of subjects: 180
Study 31192908 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release morphine (5 mg initially, hourly)
Number of subjects: 180
Study 28364408 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally prepared Bermuda grass pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally prepared Johnson grass pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally prepared careless weed pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: COMPARATOR
Intervention: Imported Bermuda grass pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: COMPARATOR
Intervention: Imported Johnson grass pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: COMPARATOR
Intervention: Imported careless weed pollen allergen extract
Number of subjects: 68
Study 28364408 — intervention group
Group type: EXPERIMENTAL
Intervention: Local and imported extracts
Number of subjects: 68
Study 28364408 — intervention group
Group type: COMPARATOR
Intervention: Imported pollen extracts
Number of subjects: 68
Study 27060050 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 2,000 IU/d
Number of subjects: 218
Study 27060050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 24182734 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT) at 25% of maximum expiratory pressure
Number of subjects: 34
Study 24182734 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT) at 75% of maximum expiratory pressure
Number of subjects: 34
Study 24182734 — intervention group
Group type: COMPARATOR
Intervention: Saliva swallowing
Number of subjects: 34
Study 24182734 — intervention group
Group type: COMPARATOR
Intervention: Water swallowing
Number of subjects: 34
Study 22674921 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated physical activity intervention (up to three face to face sessions and 10 telephone calls over eight months)
Number of subjects: 361
Study 22674921 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated physical activity intervention
Number of subjects: 361
Study 22674921 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 361
Study 19217260 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triacylglycerols (MCTs)
Number of subjects: 36
Study 19217260 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,3-diacylglycerol (DG) oil
Number of subjects: 36
Study 19217260 — intervention group
Group type: COMPARATOR
Intervention: Long-chain triacylglycerols (LCTs)
Number of subjects: 36
Study 17889760 — intervention group
Group type: EXPERIMENTAL
Intervention: Henderson capsule tension ring (HCTR, Morcher)
Number of subjects: 0
Study 17889760 — intervention group
Group type: COMPARATOR
Intervention: Original 14C Morcher capsular tension ring
Number of subjects: 0
Study 21213510 — intervention group
Group type: EXPERIMENTAL
Intervention: Single embryo transfer (fresh)
Number of subjects: 0
Study 21213510 — intervention group
Group type: COMPARATOR
Intervention: Double embryo transfer (fresh)
Number of subjects: 0
Study 21213510 — intervention group
Group type: EXPERIMENTAL
Intervention: Single embryo transfer (cumulative)
Number of subjects: 0
Study 21213510 — intervention group
Group type: COMPARATOR
Intervention: Double embryo transfer (cumulative)
Number of subjects: 0
Study 11441370 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg) in the acute study
Number of subjects: 23
Study 11441370 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg/d) in the chronic study
Number of subjects: 23
Study 11441370 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the acute study
Number of subjects: 23
Study 11441370 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the chronic study
Number of subjects: 23
Study 9530056 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo-enhanced Doppler sonography
Number of subjects: 30
Study 9530056 — intervention group
Group type: COMPARATOR
Intervention: Unenhanced Doppler sonography
Number of subjects: 30
Study 7978098 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 25
Study 7978098 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 25
Study 7978098 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 25
Study 7978098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2647040 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant replacement
Number of subjects: 20
Study 4570092 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin sulfate
Number of subjects: 0
Study 4570092 — intervention group
Group type: EXPERIMENTAL
Intervention: Phythalylsulfathiazole
Number of subjects: 0
Study 4570092 — intervention group
Group type: COMPARATOR
Intervention: Iodochlorhydroxyquin
Number of subjects: 0
Study 4570092 — intervention group
Group type: COMPARATOR
Intervention: Furazolidone
Number of subjects: 0
Study 4570092 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial treatment and anti-diarrheal agents
Number of subjects: 0
Study 30704329 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy taping
Number of subjects: 99
Study 30704329 — intervention group
Group type: COMPARATOR
Intervention: Splint immobilization
Number of subjects: 99
Study 28978289 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation to attend the clinic as a couple
Number of subjects: 37
Study 28978289 — intervention group
Group type: COMPARATOR
Intervention: Invitation to attend the clinic as a couple plus clinic-led phone and community tracing
Number of subjects: 37
Study 25693012 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 0
Study 25693012 — intervention group
Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 0
Study 22971724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint exercise
Number of subjects: 8
Study 22971724 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 8
Study 22971724 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 8
Study 22971724 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 8
Study 21868779 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (EXE)
Number of subjects: 69
Study 21868779 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (GLAR)
Number of subjects: 69
Study 21868779 — intervention group
Group type: COMPARATOR
Intervention: Exenatide (EXE) and Insulin glargine (GLAR)
Number of subjects: 69
Study 19506526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 25588
Study 19506526 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 25588
Study 19506526 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Ramipril and Telmisartan
Number of subjects: 25588
Study 19506526 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 25588
Study 16613177 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy, thrombolysis, or percutaneous coronary intervention
Number of subjects: 0
Study 16613177 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment with various pharmacological agents
Number of subjects: 0
Study 12845256 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual laser ablation combined with transurethral resection of the prostate (VLAP+TURP)
Number of subjects: 105
Study 12845256 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP) alone
Number of subjects: 105
Study 10989852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibreoptic intubation through the intubating laryngeal mask (Group L)
Number of subjects: 124
Study 10989852 — intervention group
Group type: COMPARATOR
Intervention: Fibreoptic intubation using only a fibrescope (Group C)
Number of subjects: 124
Study 9377881 — intervention group
Group type: EXPERIMENTAL
Intervention: VI strategy (increased flow back to initial set flow and then further increased by 25%)
Number of subjects: 16
Study 9377881 — intervention group
Group type: EXPERIMENTAL
Intervention: P strategy (pressure-limited breath feature coupled to a volume assist breath with pressure limit set at 75% and 100% of static elastic recoil pressure)
Number of subjects: 16
Study 9377881 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline flow dyssynchrony produced by reducing set flow by 50%)
Number of subjects: 16
Study 8230517 — intervention group
Group type: EXPERIMENTAL
Intervention: Estramustine (560 to 700 mg orally per day)
Number of subjects: 171
Study 8230517 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (15 mg/m2 by intravenous infusion every 6 weeks)
Number of subjects: 171
Study 3541419 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate slow release 120 mg once a day
Number of subjects: 21
Study 3541419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30664829 — intervention group
Group type: EXPERIMENTAL
Intervention: Child self-reported depressive symptoms
Number of subjects: 181
Study 30664829 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-report of child depressive symptoms
Number of subjects: 181
Study 30664829 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between child self-report and parent-report on child
Number of subjects: 181
Study 30664829 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with high self-reported symptoms and parents reporting low depressive symptoms
Number of subjects: 181
Study 30664829 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with low self-reported symptoms
Number of subjects: 181
Study 26688178 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative education
Number of subjects: 240
Study 26688178 — intervention group
Group type: COMPARATOR
Intervention: Usual education
Number of subjects: 240
Study 27338452 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Alcoholic Beer (NAB)
Number of subjects: 7
Study 27338452 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic Beer (AB)
Number of subjects: 7
Study 27338452 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 7
Study 24983446 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (MTX) administration via prefilled autoinjector pen
Number of subjects: 62
Study 24983446 — intervention group
Group type: COMPARATOR
Intervention: Oral methotrexate (MTX) administration
Number of subjects: 62
Study 22248564 — intervention group
Group type: EXPERIMENTAL
Intervention: web-ICAIP (Individual Coping and Alcohol Intervention Program)
Number of subjects: 183
Study 22248564 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 183
Study 22248564 — intervention group
Group type: EXPERIMENTAL
Intervention: web-ICAIP
Number of subjects: 183
Study 19071884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel 60 mg
Number of subjects: 50
Study 19071884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel 90 mg
Number of subjects: 50
Study 19071884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide Autogel 120 mg
Number of subjects: 50
Study 19071884 — intervention group
Group type: COMPARATOR
Intervention: Lanreotide IRF 7 microg/kg
Number of subjects: 50
Study 17598899 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthened multidisciplinary primary care team consultation
Number of subjects: 0
Study 17598899 — intervention group
Group type: COMPARATOR
Intervention: Usual general practitioner care
Number of subjects: 0
Study 12969172 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdilution hemodiafiltration (session B)
Number of subjects: 20
Study 12969172 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed hemodiafiltration (session D)
Number of subjects: 20
Study 12969172 — intervention group
Group type: COMPARATOR
Intervention: Dialysis (session A)
Number of subjects: 20
Study 12969172 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed hemodiafiltration (sessions C, D, and E)
Number of subjects: 20
Study 10769580 — intervention group
Group type: COMPARATOR
Intervention: Alpha-tocopherol (vitamin E) supplementation
Number of subjects: 0
Study 10769580 — intervention group
Group type: COMPARATOR
Intervention: Beta-carotene (vitamin A) supplementation
Number of subjects: 0
Study 10769580 — intervention group
Group type: COMPARATOR
Intervention: Combined supplements of several antioxidant vitamins
Number of subjects: 0
Study 10769580 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C supplementation
Number of subjects: 0
Study 9333111 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin 1.5 gm/day for 4 days
Number of subjects: 8
Study 9333111 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/day for 4 days
Number of subjects: 8
Study 9333111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8403714 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard feeding (commercial milkshake taken immediately after injection)
Number of subjects: 32
Study 8403714 — intervention group
Group type: COMPARATOR
Intervention: Posture (standing versus sitting for 10 minutes postinjection)
Number of subjects: 32
Study 8403714 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding of lipid after injection
Number of subjects: 32
Study 8403714 — intervention group
Group type: EXPERIMENTAL
Intervention: Further study of the acute effects of a milkshake in eight patients
Number of subjects: 32
Study 3780286 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg propranolol plus 12.5 mg hydrochlorothiazide twice daily
Number of subjects: 20
Study 3780286 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg acebutolol plus 25 mg hydrochlorothiazide once daily
Number of subjects: 20
Study 30896414 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolysed cow's milk formula (pHF)
Number of subjects: 25
Study 30896414 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolysed cow's milk formula (eHF)
Number of subjects: 25
Study 30896414 — intervention group
Group type: COMPARATOR
Intervention: Regular cow's milk formula (rCMF)
Number of subjects: 25
Study 30369162 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 52
Study 30369162 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID injection
Number of subjects: 52
Study 27536081 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) program, conducted for 8 weeks, 2 sessions/week
Number of subjects: 30
Study 27536081 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) did not perform any physical activity
Number of subjects: 30
Study 24603353 — intervention group
Group type: EXPERIMENTAL
Intervention: AM-101 0.81 mg/ml
Number of subjects: 248
Study 24603353 — intervention group
Group type: EXPERIMENTAL
Intervention: AM-101 0.27 mg/ml
Number of subjects: 248
Study 24603353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 22399081 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 101
Study 22399081 — intervention group
Group type: COMPARATOR
Intervention: Neutral vehicle (control)
Number of subjects: 101
Study 20466440 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-2301 (3 mg)
Number of subjects: 0
Study 20466440 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-2301 (10 mg)
Number of subjects: 0
Study 20466440 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-2301 (1 mg)
Number of subjects: 0
Study 20466440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0